PreciseDx is a New York-based AI platform that provides solutions such as cancer risk stratification and personalized treatment analytics for the healthcare industry. PreciseDx was founded in 2020. PreciseDx's headquarters is located in New York, New ... PreciseDx's President & CEO, Wayne Brinster, currently has an approval
rating of 90%. PreciseDx's primary competitors are IBEX, Paige & PathAI.
There have been no acquisitions found related to PreciseDx
Recent investment data cannot be found related to PreciseDx